Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Prif Awdur: | Tania, Umme |
---|---|
Awduron Eraill: | Haque , Md. Aminul |
Fformat: | Traethawd Ymchwil |
Iaith: | en_US |
Cyhoeddwyd: |
Brac University
2021
|
Pynciau: | |
Mynediad Ar-lein: | http://hdl.handle.net/10361/15111 |
Eitemau Tebyg
-
Biosimilar in lymphoma treatment
gan: Tanisha, Mehrin Haque
Cyhoeddwyd: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
gan: Tabassum, Turana
Cyhoeddwyd: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
gan: Tania, Umme
Cyhoeddwyd: (2023) -
Advancement of Antibody-Drug conjugates in cancer treatment: A review
gan: Sagar, Baejid Hossain
Cyhoeddwyd: (2022) -
Immunotherapeutic approaches to treat cancer: Prospects and challenges
gan: Fred, Namanda Rogers
Cyhoeddwyd: (2021)